Form 4 holding
Director
Monopar Therapeutics
- Security class
- Common Stock
- Shares / value
- 235,863
- Estimated value
- $80,241
- Report date
- 31 Dec 2023
- Price
- $0.3402
- Ownership
- Direct
Michael J. Brown - Director at Monopar Therapeutics
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- MNPR on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Michael J. Brown since 16 Aug 2025
Reported holdings for Michael J. Brown in Monopar Therapeutics
Form 4 holding
Director
Monopar Therapeutics
- Security class
- Common Stock
- Shares / value
- 166,667
- Estimated value
- $56,700
- Report date
- 31 Dec 2023
- Price
- $0.3402
- Ownership
- Indirect
Form 4 holding
Director
Monopar Therapeutics
- Security class
- Restricted Stock Units
- Shares / value
- 0
- Estimated value
- Report date
- 31 Dec 2023
- Price
- $0.3402
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Michael J. Brown in Monopar Therapeutics
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.